Brind.
  1. Phio Pharmaceuticals Corp. is developing therapeutics for cancer using INTASYL technology.

Phio Pharmaceuticals Corp., a U.S. manufacturer, provides drug substance development services.

2 reports, 2 independent Updated Oct 13
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Phio Pharmaceuticals Corp., a U.S. manufacturer, provides drug substance development services.

How it developed

Newest first. Tap a step to see who reported it.
  1. PH-762 development advances following a successful manufacturing milestone.1 source
  2. Specific operational detail about the company's business activities.1 source

Keep exploring

Part of

Phio Pharmaceuticals Corp. is developing therapeutics for cancer using INTASYL technology. All 1 developments

Coverage

Newest first; wire copies grouped
  • intelligencer.ca
  • NewsfilePhio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance Agreement covers contract development and manufacturing of lead compound PH-762 King of Prussia, Pennsylvani